NEKTAR THERAPEUTICS — Director's Dealing 2015

Sep 15, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2015-09-11

Reporting Person: WHITFIELD ROY A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-09-11	Common Stock	M	15000	$8.81	Acquired	15000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-09-11	Stock Option	$8.81	M	15000	Disposed	2015-09-18	common stock (15000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	20000	Indirect